Clarity Pharmaceuticals Ltd (ASX:CU6)
2.250
-0.080 (-3.43%)
Jun 6, 2025, 4:10 PM AEST
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 748.75 million as of June 6, 2025. Its market cap has decreased by -44.66% in one year.
Market Cap
748.75M
Enterprise Value
637.56M
Revenue
10.78M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.25
Market Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 748.75M, an increase of 94.89%. That is a compound annual growth rate of 19.30%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 5, 2025 | 748.75M | -44.03% |
Dec 31, 2024 | 1.34B | 168.49% |
Dec 29, 2023 | 498.26M | 93.82% |
Dec 30, 2022 | 257.07M | 35.63% |
Dec 31, 2021 | 189.54M | -50.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CSL Limited | 119.22B |
Pro Medicus | 29.60B |
Cochlear | 17.65B |
Sonic Healthcare | 12.77B |
Telix Pharmaceuticals | 9.20B |
Ramsay Health Care | 8.83B |
Ansell | 4.56B |
Regis Healthcare | 2.40B |